Cellyan Biotechnology/$HKPD
1D1W1MYTD1Y5YMAX
About Cellyan Biotechnology
Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.
- Ticker
- $HKPD
- Sector
- Mobility
- Primary listing
- NASDAQ
- Employees
- 11
- Headquarters
- Yau Tong, Hong Kong
- Website
- www.9zt.hk
HKPD Metrics
BasicAdvanced
$9.5M
-
-$0.05
-
-
Price and volume
Market cap
$9.5M
52-week high
$1.82
52-week low
$0.31
Average daily volume
902K
Financial strength
Current ratio
3.859
Quick ratio
1.694
Long term debt to equity
0.681
Total debt to equity
13.129
Interest coverage (TTM)
-7.51%
Profitability
EBITDA (TTM)
-0.918
Gross margin (TTM)
10.32%
Net profit margin (TTM)
-8.46%
Operating margin (TTM)
-7.48%
Effective tax rate (TTM)
-0.68%
Revenue per employee (TTM)
$1,220,000
Management effectiveness
Return on assets (TTM)
-5.64%
Return on equity (TTM)
-15.59%
Valuation
Price to revenue (TTM)
0.71
Price to book
1
Price to tangible book (TTM)
1
Price to free cash flow (TTM)
-12.017
Free cash flow yield (TTM)
-8.32%
Free cash flow per share (TTM)
-0.034
Growth
Revenue change (TTM)
-33.87%
Earnings per share change (TTM)
1,723.39%
3-year revenue growth (CAGR)
2.28%
3-year earnings per share growth (CAGR)
-30.80%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.